Megan V. Cannon - Concepedia

Author

Megan V. Cannon

University Medical Center Groningen

Also Known As

Cannon, M. V., M. V. Cannon, Megan Cannon, Megan V Cannon, Megan V. Cannon, Molly Cannon

Publications

784

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen Netherlands Heart Institute Karolinska Institutet

About

Megan V. Cannon is an author at University Medical Center Groningen specializing in medicine, hypertension, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	214
2	Pharmacology	2	2	101
3	Hypertension	2	2	101
4	Cardiorenal Syndromes	1	1	28
5	Cell Signaling	1	1	28

Megan V. Cannon

Publications

716

Citations

H-Index

Page 1

	Year	Citations
Repair of Traumatic Skeletal Muscle Injury with Bone-Marrow-Derived Mesenchymal Stem Cells Seeded on Extracellular Matrix Edward Merritt, Megan V. Cannon, David W. Hammers, Tissue Engineering Part A	2010	149
52 Genetic Loci Influencing Myocardial Mass Pim van der Harst, Jessica van Setten, Niek Verweij, Journal of the American College of Cardiology	2016	134
ACE inhibition attenuates radiation-induced cardiopulmonary damage Sonja J. van der Veen, Ghazaleh Ghobadi, Rudolf A. de Boer, Radiotherapy and Oncology Cardiovascular ToxicityAce InhibitionHeart FailureRadiation EffectRadiation Effects	2014	113
The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload Laura M.G. Meems, Megan V. Cannon, Hasan Mahmud, The Journal of Steroid Biochemistry and Molecular Biology Diastolic DysfunctionHypertensionMedicinePhysiologyChronic Kidney Disease	2012	73
Cardiac <scp>LXR</scp> α protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization Megan V. Cannon, Herman H.W. Silljé, Jürgen W. A. Sijbesma, EMBO Molecular Medicine	2015	59
Atrial Remodeling Is Directly Related to End-Diastolic Left Ventricular Pressure in a Mouse Model of Ventricular Pressure Overload Anne Margreet de Jong, Isabelle C. Van Gelder, Inge Vreeswijk‐Baudoin, PLoS ONE	2013	53
LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes Megan V. Cannon, Herman H.W. Silljé, Jürgen W. A. Sijbesma, Diabetologia	2015	41
The liver X Receptor Agonist AZ876 Protects Against Pathological Cardiac Hypertrophy and Fibrosis Without Lipogenic Side Effects Megan V. Cannon, Hongjuan Yu, Wellington M. Candido, European Journal of Heart Failure	2015	36
Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anaemia Hasan Mahmud, Willem P.T. Ruifrok, B. Daan Westenbrink, Cardiovascular Research	2013	30
Regulation of the (pro)renin–renin receptor in cardiac remodelling Hasan Mahmud, Herman H.W. Silljé, Megan V. Cannon, Journal of Cellular and Molecular Medicine HypertensionHeart FailureCardiovascular FunctionPost-mi Rat HeartCell Signaling	2011	28

Page 1